Resmed’s decision to sell MatrixCare to PE firm Frazier Healthcare Partners comes less than a decade after its $750m ...

An industrial X-ray CT scan shows the internal design of the ResMed AirSense 10 AutoSet CPAP device used by millions of sleep ...

Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The new machine has many ...

Philips’ home ventilator recall is still in full force—spanning more than 18 months and over 5 million sleep apnea devices around the globe—and competitor ResMed has been looking to pick up the slack ...

ResMed (NYSE: RMD) finds itself in an investment limbo as revolutionary weight loss drugs create both immediate opportunities and long-term existential questions for the sleep apnea device maker.

Air Voel continues to strengthen its commitment to improving sleep health for Canadians by providing dependable ResMed BiPAP ...